Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-11-004463)

Filing Details

Accession Number:: 0001104659-11-004463
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-02 16:14:38
Reporting Period:: 2011-01-31

Filing Date:: 2011-02-02
Accepted Time:: 2011-02-02 16:14:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192128	M Luke Beshar	550 Hills Drive Bedminster NJ 07921	Svp &Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-31	50,000	$4.05	50,000	No	4	M	Direct
Common Stock	Disposition	2011-01-31	50,000	$10.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-01-31	50,000	$0.00	50,000	$4.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
150,000	2008-11-20	2017-11-20	No	4	M	Direct

Footnotes

These shares were sold pursuant to a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
On November 20, 2007, the Reporting Person received a grant of 200,000 stock options under the Issuer's 1998 Stock Option Plan. 28% of the options vested on the first anniversary of the date of grant, with 2% of the options vesting each month thereafter.